Review of mendelian randomization studies on age at natural menopause

Xiao Zhang, Zhao Huangfu, Shaowei WangFrontiers in Endocrinology 2023 · DOI

TL;DR

This review synthesizes 31 Mendelian randomization (MR) studies to determine whether the timing of menopause is a cause or a consequence of various health conditions. The findings confirm that while early menopause causally increases risks for osteoporosis and type 2 diabetes, late menopause is linked to higher risks of breast and lung cancers but may offer protection against Parkinson’s disease.

What Problem Does This Paper Address?

For decades, doctors have observed that the age at which a woman reaches natural menopause (ANM) correlates with her long-term health. Early menopause is often linked to heart disease and bone loss, while late menopause is associated with certain cancers. However, traditional observational studies struggle with a "chicken or egg" problem: does early menopause cause these diseases, or do the underlying health conditions (or shared lifestyle factors like smoking and nutrition) cause early menopause?

To solve this, researchers use Mendelian randomization (MR). By using genetic variants (SNPs) assigned at birth as "natural" proxies for menopause timing, researchers can bypass the confounding factors and reverse causality that plague standard epidemiology. This paper reviews the current state of MR research to clarify which of these health associations are truly causal.

Methods

This is a systematic review of 31 original MR studies published before March 2023. The authors categorized these studies based on whether ANM was treated as:

  1. The Outcome: Identifying genetic risk factors (like education or BMI) that change when menopause occurs.
  2. The Exposure: Determining how the timing of menopause causes downstream diseases.
  3. The Mediator: Seeing if menopause timing is the "middleman" through which early-life factors (like birth weight) influence later disease risk.

The review highlights the shift from simple one-sample MR to more complex Multivariable MR (MVMR) and Mediation MR, which allow researchers to account for multiple correlated traits simultaneously.

Datasets

The reviewed studies primarily utilized large-scale summary statistics from Genome-Wide Association Studies (GWAS). Key data sources include:

  • The UK Biobank: A massive repository of genetic and health data from half a million UK participants.
  • ReproGen Consortium: Specifically focused on the genetics of reproductive aging.
  • Breast Cancer Association Consortium (BCAC): Used for investigating the link between menopause and cancer subtypes.
  • International Consortia for CVD and Diabetes: Providing the genetic backbone for metabolic and heart health analyses.

Key Insights and Ideas

  • The "Fast Life" Strategy: MR evidence suggests that reproductive milestones are genetically linked. Early age at menarche (first period), early age at first birth, and early age at first sexual intercourse are all causally linked to earlier menopause. This supports the "life history theory," where biological resources are allocated toward early reproduction at the cost of a shorter reproductive lifespan.
  • Education as a Biological Driver: One of the most robust findings is that higher educational attainment is causally linked to later menopause. This suggests that socioeconomic factors may influence biological aging through pathways that go beyond simple lifestyle choices.
  • The Estrogen Double-Edged Sword: Late menopause is a clear causal risk factor for breast, endometrial, and lung cancers. This is likely due to the prolonged exposure to endogenous estrogens, which can promote tumor growth in sensitive tissues.
  • CVD Paradox: While observational studies strongly link early menopause to heart disease, MR results are more nuanced. Some studies suggest the link might be due to shared genetic pathways or "collider bias" rather than menopause directly causing heart attacks.

Key Results

  • Early Menopause (EM) Causes: Increased risk of osteoporosis and fractures, higher Type 2 Diabetes risk, and elevated HbA1c levels.
  • Late Menopause (LM) Causes: Increased systolic blood pressure, higher risk of breast cancer (specifically ER+ subtypes), endometrial cancer, and lung cancer.
  • Protective Effects: Late menopause is causally associated with a lower risk of Parkinson’s disease and increased longevity.
  • Mediation: ANM was found to be a significant mediator between childhood body size and adult breast cancer risk.

Limitations and Future Work

The authors identify several critical gaps:

  • Ancestral Bias: The vast majority of MR studies on menopause have been conducted in populations of European descent. Because genetic architectures differ, these results may not be fully generalizable to other ethnic groups.
  • Inconsistent Instruments: Different studies use different sets of SNPs (instrumental variables), leading to conflicting results—particularly regarding smoking and obesity.
  • Pleiotropy: Some genetic variants used to proxy for menopause might also affect other traits (like BMI) directly, which can "pollute" the causal analysis.
  • Future Directions: The authors call for more trans-ancestry MR studies and the use of more specific genetic variants that relate to DNA damage response (DDR) pathways to better understand the mechanisms of reproductive aging.

Summary updated

Abstract

Menopause marks the end of the reproductive phase of life. Based on epidemiological studies, abnormal age at natural menopause (ANM) is thought to contribute to a number of adverse outcomes, such as osteoporosis, cardiovascular disease, and cancer. However, the causality of these associations remains unclear. A powerful epidemiological method known as Mendelian randomization (MR) can be used to clarify the causality between ANM and other diseases or traits. The present review describes MR studies that included ANM as an exposure, outcome and mediator. The findings of MR analyses on ANM have revealed that higher body mass index, poor educational level, early age at menarche, early age at first live birth, early age at first sexual intercourse, and autoimmune thyroid disease appear to be involved in early ANM etiology. The etiology of late ANM appears to be influenced by higher free thyroxine 4 and methylene tetrahydrofolate reductase gene mutations. Furthermore, early ANM has been found to be causally associated with an increased risk of osteoporosis, fracture, type 2 diabetes mellitus, glycosylated hemoglobin, and the homeostasis model of insulin resistance level. In addition, late ANM has been found to be causally associated with an increased systolic blood pressure, higher risk of breast cancer, endometrial cancer, endometrioid ovarian carcinoma, lung cancer, longevity, airflow obstruction, and lower risk of Parkinson's disease. ANM is also a mediator for breast cancer caused by birth weight and childhood body size. However, due to the different instrumental variables used, some results of studies are inconsistent. Future studies with more valid genetic variants are needed for traits with discrepancies between MRs or between MR and other types of epidemiological studies.
BibTeX
@inproceedings{zhang2023review,
  author = {Xiao Zhang and Zhao Huangfu and Shaowei Wang},
  title = {{Review of mendelian randomization studies on age at natural menopause}},
  booktitle = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1234324},
}
Figure